stonks4u
Sign up free
LUCD logo

LUCD Lucid Diagnostics Inc.

NASDAQ Global Market · Medical - Devices · Healthcare

$0.97
+0.00 (+0.29%)

Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux disease (GERD), commonly referred to as chronic heartburn or acid reflux, especially those at increased risk of developing precancerous esophageal conditions or the particularly aggressive esophageal adenoc…

Market Cap: $184.61Mwww.luciddx.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
100
Aug 13Aug 13

Quote

Day Range
$0.96 – $1.00
52-Week Range
$0.86 – $1.63
Volume
$550.6K
Market Cap
$184.61M
50-Day Avg
$0.99
200-Day Avg
$1.12
Prev Close
$0.96
Open
$0.97

Valuation & Ratios

P/E Ratio
-1.58
EPS
$-0.57
P/B Ratio
10.16
P/S Ratio
23.61
Debt/Equity
2.36
Current Ratio
1.31
Dividend Yield
+0.0%
Gross Margin
-60.3%

Returns & Efficiency

Return on Equity
-530.4%
Return on Assets
-143.4%
FCF Yield
-41.8%
EV/EBITDA
-1.79

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$4.71M$-58.01M$-0.69
2024$4.35M$-45.53M$-1.05
2023$2.43M$-52.67M$-1.26
2022$377.0K$-56.17M$-1.55
2021$500.0K$-28.08M$-0.78

Social Signal Score

51
5d
51
2 mentions
—
30d
51
2 mentions
—
60d
51
2 mentions
—
90d
51
2 mentions
—
news: 2

Earnings

Mon, Nov 16(in 3 months)

Consensus estimate $-0.05 per share

0of 7 quarters beat consensus

Typical surprise -40.0% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 13$-0.06 vs $-0.06miss
  • Thu, May 14$-0.07 vs $-0.05miss
  • Wed, Mar 25$-0.10 vs $-0.07miss
  • Wed, Nov 12$-0.10 vs $-0.06miss
  • Wed, Aug 13$-0.10 vs $-0.09miss
  • Wed, May 14$-0.16 vs $-0.09miss

Estimates and results for LUCD via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

LUCDhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (2)

  • Newsseekingalpha.com·1d ago·Positive

    Lucid Diagnostics Inc. (LUCD) Q2 2026 Earnings Call Transcript Lucid Diagnostics Inc. (LUCD) Q2 2026 Earnings Call Transcript

    View source ↗
  • Newszacks.com·2d ago·Negative

    Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Lags Revenue Estimates Lucid Diagnostics Inc. (LUCD) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.1 per share a year ago.

    View source ↗